| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |